Even as AstraZeneca has paused the trials of its Covid-19 vaccine candidate after one of the participants in the UK developed an unexplained illness, more than 100 volunteers in India have completed the crucial week after receiving injections in the trials in phase two humans showing no adverse reaction. . …
Read More »Oxford Vaccine Trials in India Offer Hope Despite AstraZeneca Buffer
